The past ten years has seen the Forbion team make over 40 investments across Europe and the US, resulting in top-quartile returns. During this period we have also served on the Board of Directors of nearly all our portfolio Companies.
The team's complementary skill set provides insight into most areas of drug discovery and development, including small molecules, anti-sense technology, biologicals, gene therapy, scaffold technology, diagnostics and medicinal chemistry. Technical knowledge of medical devices, manufacturing, clinical development, regulatory filings and protocol approvals are key assets of our team. In terms of medical specialties, our team has clinical experience in gastroenterology, respiratory medicine, intensive care medicine, therapeutic immunomodulation, haemostasis & thrombosis, infectious diseases, arthritis & pain, female health and CNS diseases.
Our combined knowledge and networks in the field and our proven ability and experience to grow companies will be put to work when working with management to execute on their business plans